Johns Hopkins develops new liquid biopsy test for breast cancer
The LBx-BCM test is compatible with the commercially available GeneXpert molecular testing platform.

The LBx-BCM test is compatible with the commercially available GeneXpert molecular testing platform.
The new device uses a blood sample to analyse platelet clotting and white cell inflammation responses.
The CoDE-HF tool was highly accurate in hard-to-diagnose patient populations, such as the elderly.
Business optimism increased in May 2022 compared to April 2022, amid concerns over rising costs, economic slowdown, and the Ukraine…
The Sleepio app leverages an AI algorithm to offer customised digital cognitive behavioural therapy for insomnia (CBT-I).
The test identified around 79% of early-stage bowel cancers in a primary care trial.
The new technology may reduce reliance on imported radioactive isotope tracers for such procedures.
The nanobots can remove bacteria located deep inside microscopic canals in the teeth.
Thank you for subscribing to Medical Device Network